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Abstract A gene has been cloned from Trypanosoma brucei
which encodes a protein of 144 amino acid residues containing
the thioredoxin-like motif WCPPCR. Overexpression of the
gene in E. coli resulted in 4 mg pure protein from 100 ml
bacterial cell culture. Recombinant T. brucei tryparedoxin acts
as a thiol-disulfide oxidoreductase. It is spontaneously reduced
by trypanothione. This dithiol, exclusively found in parasitic
protozoa, also reduces E. coli glutaredoxin but not thioredoxin.
The trypanothione/tryparedoxin couple is an effective reductant
of T. brucei ribonucleotide reductase. Like thioredoxins it has a
poor GSH:disulfide transhydrogenase activity. The catalytic
properties of tryparedoxin are intermediate between those of
classical thioredoxins and glutaredoxins which indicates that
these parasite proteins may form a new class of thiol-disulfide
oxidoreductases.
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1. Introduction
Thiol-disul¢de oxidoreductases with the active site motif
CXXC are found in all living cells. Well known representa-
tives of this large protein family are the thioredoxins (CGPC),
glutaredoxins (CPYC), eukaryotic protein-disul¢de isomerases
(CGHC) and the bacterial periplasmatic protein thiol :disul-
¢de oxidoreductases DsbA (CPHC) [1]. An important func-
tion of thioredoxins and glutaredoxins ^ small proteins with
an Mr of 12 000 and 10 000, respectively ^ is the delivery of
reducing equivalents to ribonucleotide reductase. Oxidized
thioredoxin formed in the reaction is then reduced by
NADPH catalyzed by thioredoxin reductase. Oxidized gluta-
redoxin reacts spontaneously with glutathione and the result-
ing glutathione disul¢de is subsequently reduced by gluta-
thione reductase [2]. Trypanosomes, leishmania and
amoebas ^ the causative agents of severe tropical diseases ^
lack the nearly ubiquitous glutathione/glutathione reductase
system. Glutathionyl spermidine conjugates such as trypano-
thione [N1,N8-bis(glutathionyl)spermidine] are their main low
molecular weight thiols which are kept reduced by the enzyme
trypanothione reductase [3^5].
In all eukaryotes studied the synthesis of deoxyribonucleo-
tides is a thiol-dependent reaction. Recently, the genes of ri-
bonucleotide reductase from Trypanosoma brucei have been
cloned and overexpressed [6,7]. The uniqueness of the trypa-
nothione metabolism raises the question if this dithiol is the
donor of reducing equivalents for the parasite synthesis of
deoxyribonucleotides and if the reaction is catalyzed by a
speci¢c protein. One interesting candidate is ‘tryparedoxin’.
This protein ^ which has an Mr of 16 000 and contains a
CPPC motif ^ has recently been isolated from Crithidia fas-
ciculata as a component of a trypanothione-dependent peroxi-
dase system [8,9]. Here we report the cloning and overexpres-
sion of the gene of a tryparedoxin from the African parasite
Trypanosoma brucei brucei. The catalytic properties of the
recombinant protein are compared with those of Escherichia
coli thioredoxin and glutaredoxin.
2. Materials and methods
2.1. Materials
Trypanothione disul¢de was purchased from Bachem, Switzerland.
E. coli glutaredoxin was obtained from IMCO, Sweden. E. coli thio-
redoxin was from Calbiochem and HEDS from Aldrich.
Recombinant T. cruzi trypanothione reductase [10,11], human glu-
tathione reductase [12] and T. brucei ribonucleotide reductase [6,7]
were puri¢ed as described. The plasmids of the two genes of T. brucei
ribonucleotide reductase were kindly provided by Drs. A. Hofer and
L. Thelander, Umeaî University, Umeaî, Sweden. E. coli thioredoxin
reductase was a kind gift of Dr. Charles Williams, University of
Michigan, Ann Arbor, MI, USA. The E. coli strain A179 (garB10,
fhuA22, ompF627(T2 R), fadL701(T2 R), relA1, pit-10, spoT1,
trxA14: :kan, mcrB1, creC510) [13] was obtained from Dr. Mary Ber-
lyn, E. coli Stock Center, Yale University, USA.
2.2. PCR ampli¢cation and sequencing
Total RNA of long slender bloodstream T. brucei was reverse tran-
scribed into single-strand cDNA as described [7,14]. Two degenerate
primers (tpx1, 5P-TGGTG(CT)CCICCITG(CT)(AC)GIGGITT(CT)
and tpx2, 5P-GT(AG)AAICCIC(GT)(AG)CAIGGIGG(AG)CACCA)
which covered the active site motif were derived from the partial
protein sequence of C. fasciculata tryparedoxin [8]. The 5P end of
the gene was ampli¢ed from the cDNA using tpx2 and a spliced leader
primer (5P-TAGAACCAGTTTCTGTACTATATTG) (94‡C, 2 min;
94‡C, 30 s; 60‡C, 30 s; 72‡C, 2 min; 30 cycles; 72‡C, 5 min). For
cloning the 3P end tpx1 and an oligo(T) primer were used (94‡C,
2 min; 94‡C, 30 s; 50‡C, 30 s; 72‡C, 3 min; 30 cycles; 72‡C, 3 min).
Both fragments were cloned into the pBluescript SK(+) vector (Stra-
tagene) for sequencing.
The complete gene was obtained from the cDNA using a 3P primer
which contained an additional BglII cleavage site (5P-AGATCTTCA-
CAGACAGCATGGCATCTC) and a 5P primer (5P-ATGTCTGG-
CCTCGCCAAGTATCTTCC). PCR was carried out with Pfu poly-
merase (94‡C, 2 min; 94‡C, 30 s; 55‡C, 30 s; 72‡C, 2 min; 30 cycles;
72‡C, 5 min). The PCR product was cloned into the pQE-60 vector
(Qiagen) predigested by NcoI and mung bean nuclease I.
DNA was sequenced by the dideoxynucleotide chain termination
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method using the T7 Sequencing Kit (Pharmacia Biotech). Both
strands were completely sequenced.
2.3. Expression of the gene and puri¢cation of the recombinant
tryparedoxin
The E. coli strain A179 [13] which is de¢cient in thioredoxin was
used for the expression of the T. brucei tryparedoxin gene. Competent
cells were transfected with the pQE-60/tpx plasmid. A 100 ml culture
of transformed cells in LB medium containing 100 Wg/ml carbenicillin
and 100 Wg/ml kanamycin was grown at 37‡C to an OD600 of 0.4.
Expression was induced with 100 WM IPTG (isopropyl-L-D-thiogalac-
topyranoside) overnight at 37‡C. The cells were harvested and disin-
tegrated by sonication. The cell debris was removed by centrifugation
and ammonium sulfate was added to the supernatant to a saturation
of 45%. After centrifugation the pellet was discarded and the ammo-
nium sulfate concentration in the supernatant was increased to 68%.
After centrifugation the protein pellet was dissolved in 100 mM po-
tassium phosphate, 1 mM EDTA, pH 7.0 and chromatographed on a
Superdex 75 HiLoad 16/60 FPLC column (Pharmacia). This step re-
sulted in a fraction of pure T. brucei tryparedoxin as judged by PAGE
on an 18% SDS gel. The protein concentration was determined using
the bicinchoninic acid kit (Pierce). For pure tryparedoxin a protein
concentration of 1 mg/ml corresponds to a vA280 = 1.7. From a one
liter culture of recombinant E. coli cells 40 mg of pure protein was
obtained.
2.4. Glutathione:HEDS transhydrogenase assay
1 ml assay mixture contained 200 WM NADPH, 150 mU gluta-
thione reductase, 1 mM GSH, 750 WM HEDS in 100 mM Tris-HCl,
1 mM EDTA, pH 8.0. The reaction was started by adding a sample of
T. brucei tryparedoxin, E. coli glutaredoxin or thioredoxin. The GSSG
formed is reduced by NADPH in the coupled glutathione reductase
reaction. The absorbance decrease at 340 nm due to NADPH oxida-
tion is followed at 25‡C [15]. The activities were corrected for the rate
of the spontaneous reduction of HEDS by GSH.
2.5. Thiol-disul¢de exchange with trypanothione
A 90 Wl assay mixture contained 100 WM NADPH, 1.34 mU TR, 50
WM T(SH)2 and 10^30 WM of the respective CXXC protein (T. brucei
tryparedoxin, E. coli thioredoxin or glutaredoxin). Trypanothione di-
sul¢de generated in the reaction is reduced by trypanothione reductase
(TR). The absorbance decrease at 340 nm due to NADPH oxidation
is followed at 25‡C.
An apparent Km value of T. brucei tryparedoxin for T(SH)2 was
obtained using GSSG as a ¢nal electron acceptor [9]. The reaction
mixture contained 130 WM NADPH, 400 mU TR, 20^110 WM T(SH)2
and 4.4 mM GSSG. The reaction was started by adding 1 WM trypar-
edoxin. The NADPH consumption was followed at 340 nm and cor-
rected for the spontaneous reaction between T(SH)2 and GSSG.
2.6. Thioredoxin reductase assay
90 Wl reaction mixture contained 130 WM NADPH and E. coli
thioredoxin reductase in 100 mM potassium phosphate, 2 mM
EDTA, pH 7.4. The reaction was started by adding 14 WM T. brucei
tryparedoxin, E. coli thioredoxin, or glutaredoxin. The NADPH ox-
idation was followed at 340 nm.
2.7. Ribonucleotide reductase assay
Ribonucleotide reductase activity was determined from the rate of
reduction of [3H]GDP to dGDP as described for CDP reduction [16].
The reaction products were separated by HPLC [17].
3. Results and discussion
3.1. Cloning and sequencing of the T. brucei tryparedoxin gene
Recently a protein, isolated from the insect parasite Crithi-
dia fasciculata, was reported to be involved in a peroxidase
cascade and to contain the unusual thioredoxin-like sequence
WCPPCRGF [8]. From this peptide sequence a sense and an
antisense primer were derived. PCR ampli¢cations on T. bru-
cei cDNA were performed with either a poly(T) primer or a
spliced leader specifying primer in combination with the re-
spective gene speci¢c primer. The spliced leader which is
added by trans-splicing is the very 5P end of all trypanosomal
mRNAs. The PCR ampli¢cations yielded two fragments (244
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Fig. 1. Nucleotide sequence and deduced protein sequence of T. brucei tryparedoxin. The ATG start codon, the TGA stop codon, and the
poly(A) stretch are underlined.
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bp and 750 bp, respectively) which covered the whole se-
quence of the gene. The complete gene was also ampli¢ed
from the T. brucei cDNA. The spliced leader addition site is
found 80 nucleotides upstream of the start codon. The follow-
ing open reading frame of 432 bp corresponds to a deduced
protein sequence of 144 amino acid residues (Fig. 1). The 3P
non-coding region comprises 350 bp followed by a poly-A
stretch.
3.2. Structural comparison of tryparedoxin with classical
thioredoxins and other proteins containing a CPPC motif
The deduced protein sequence of T. brucei tryparedoxin is
144 residues long and exhibits a WCPPCR motif. Several
proteins containing this motif have been identi¢ed in the
last 3 years. Most of them are of plant origin like three thi-
oredoxins h from Arabidopsis thaliana [18]. Others have been
identi¢ed as genes in invertebrates, for instance a thioredoxin-
like protein of Caenorhabditis elegans [19]. Mouse nucleore-
doxin [20], tryparedoxin from Crithidia fasciculata [9] and a
periplasmatic protein-disul¢de oxidoreductase from Paracoc-
cus denitri¢cans [21] also contain this motif. The CPPC motif
is clearly distinct from the classical sequences of thioredoxins
(CGPC), glutaredoxins (CPYC) or protein disul¢de oxidore-
ductases (CGHC). Fig. 2 gives an alignment of six proteins
with the WCPPCR motif together with the sequence of E. coli
thioredoxin [22]. Except for the common motif, the proteins
show relatively little sequence similarity. When comparing T.
brucei tryparedoxin with the C. elegans protein, thioredoxin h
of A. thaliana, the protein-disul¢de oxidoreductase of P. de-
nitri¢cans, mouse nucleoredoxin and E. coli thioredoxin 32,
24, 16, 38 and 26% of all compared positions are found to be
occupied by identical residues. An alignment of T. brucei try-
paredoxin with human glutaredoxin revealed only 15% resi-
dues in common (data not shown). The primary structures of
T. brucei and C. fasciculata tryparedoxins show 57% identity
re£ecting a much closer relationship between the two parasitic
proteins. For none of the proteins containing a WCPPC motif
structural information is so far available. On the other hand,
valuable 3-dimensional models for di¡erent thioredoxins ^
despite often low sequence similarities ^ have been con-
structed based on the high resolution structure of E. coli thi-
oredoxin [23]. In the following the primary structure of
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Fig. 2. Alignment of T. brucei tryparedoxin with other WCPPCR-containing proteins as well as E. coli thioredoxin. C. fascic., Crithidia fascicu-
lata tryparedoxin (fragments) [8] ; C. elegans, Caenorhabditis elegans thioredoxin-like protein (clone) ([19]; accession number U23511); A. thali-
ana, Arabidopsis thaliana thioredoxin h ([18]; accession number Z35473); P. denitr., Paracoccus denitri¢cans periplasmatic protein-disul¢de oxi-
doreductase ([21]; accession number Z71971); Mouse Nucl, mouse nucleoredoxin ([20]; accession number X92750); E. coli, Escherichia coli
thioredoxin ([22]; accession number M54881). Of the 435 residues long sequence of mouse nucleoredoxin only residues 128^321 are depicted.
Residues which are found in at least ¢ve of the seven aligned sequences are given in bold letters. Redox-active Cys pair. *Residues which are
highly conserved in thioredoxins of di¡erent species and which are also found in T. brucei tryparedoxin.
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T. brucei tryparedoxin will be discussed in light of the 3-di-
mensional structure of E. coli thioredoxin [24,25]. Trypare-
doxin is 35 residues longer than E. coli thioredoxin. The se-
quence alignment indicates that most of the additional
residues appear as one long insertion starting around position
47 of E. coli thioredoxin. In light of the 3-dimensional struc-
ture of thioredoxin this stretch is supposed to protrude from
the protein surface. Besides the active site motif, a second
cluster of conserved residues starts at Gly-105 of T. brucei
tryparedoxin (Gly-71 of E. coli thioredoxin; Fig. 2). In the
structure of thioredoxin this region ^ which includes the con-
served only cis proline residue ^ is spatially adjacent to the
redox-active site [24,25] and is involved in major conforma-
tional changes upon reduction of the active site disul¢de [26].
About one third of all residues are conserved within the
thioredoxin family [23]. These residues form the active site,
are essential for the high thermal stability of the proteins, or
are involved in the interaction with other proteins. Many of
them are also found in the sequence of tryparedoxin (residues
marked with an asterisk in Fig. 2) but there are a few inter-
esting exceptions. The most obvious exchanges occur at the
active site where Ser-36 and Pro-41 replace Trp-28 and Gly-33
of E. coli thioredoxin. The internal salt bridge between Asp-26
and Lys-57 in E. coli thioredoxin which is generally found in
disul¢de oxidoreductases [27] is obviously missing in trypar-
edoxins, nucleoredoxin and the C. elegans protein since the
acidic residue at this position is replaced by a tyrosine. In E.
coli thioredoxin, mutation of Asp-26 to an alanine increases
the stability of the protein; the mutant protein still serves as
substrate of ribonucleotide reductase but the Km value is 10-
fold increased [28].
3.3. Overexpression and puri¢cation of recombinant T. brucei
tryparedoxin
The T. brucei tpx gene was overexpressed in the thioredox-
in-de¢cient E. coli strain A179 [13]. The recombinant protein
was puri¢ed by fractionated ammonium sulfate precipitation
and subsequent gel chromatography on Superdex 75. In order
to exclude any contamination with a bacterial glutaredoxin
only the very ¢rst fractions of the elution peak which had
been shown by SDS-PAGE to be homogenous were used
for the kinetic studies described below. From 100 ml E. coli
culture 4 mg of recombinant protein was puri¢ed.
3.4. Catalytic properties of T. brucei tryparedoxin
Recombinant T. brucei tryparedoxin was studied for its
ability to catalyze classical reactions of thiol-disul¢de oxidore-
ductases. Glutaredoxins have high activities as general GSH-
disul¢de oxidoreductases [15]. As shown in Table 1, in the
GSH:HEDS transhydrogenase reaction tryparedoxin behaves
like thioredoxin being a very poor catalyst of the glutathione-
dependent disul¢de reduction. This ¢nding is in agreement
with the primary structure of the protein (Fig. 1) which
does not give any indication for a speci¢c glutathione binding
site [29].
Regeneration of thioredoxin and glutaredoxin from their
respective disul¢de forms follows di¡erent mechanisms. In
thioredoxins the dithiol form is restored in an NADPH-de-
pendent reaction catalyzed by thioredoxin reductase. In con-
trast, glutaredoxin disul¢des are reduced spontaneously by
glutathione and the GSSG formed is then reduced by
NADPH and glutathione reductase [2]. In trypanosomatids,
glutathione reductase is replaced by trypanothione reductase
which catalyzes the reduction of trypanothione disul¢de by
NADPH [3,4,30]. In C. fasciculata the trypanothione system
has been shown to be involved in a unique cascade catalyzing
the detoxication of hydroperoxides [8,31]. A thioredoxin-like
protein with an Mr of 16 000 and an active site WCPPC motif
is a component of this peroxidase system. This CXXC protein
^ named tryparedoxin ^ transfers the reducing equivalents
from trypanothione to a peroxiredoxin-type peroxidase which
then reduces hydroperoxides [8,9]. This mechanism comprises
the spontaneous reduction of tryparedoxin by trypanothione.
The T. brucei protein described here shares 57% of all residues
with the crithidial tryparedoxin. We therefore studied the re-
duction of T. brucei tryparedoxin by trypanothione in com-
parison to other CXXC proteins. As shown in Table 1, reduc-
tion of tryparedoxin by trypanothione is very fast (Table 1).
E. coli glutaredoxin is also readily reduced by the dithiol but
the respective rate of thioredoxin reduction is only 5% that for
tryparedoxin. The values given in Table 1 are apparent rates
since trypanothione reductase was limiting in the assay sys-
tem; in the presence of saturating concentrations of trypano-
thione reductase the reactions were too fast to be measured.
The results may indicate that in vivo tryparedoxin ^ like glu-
taredoxin, but in contrast to thioredoxin ^ is non-enzymically
regenerated by thiol/disul¢de exchange. On the other hand, T.
brucei tryparedoxin is readily reduced by human thioredoxin
reductase (S. Gromer and R.H. Schirmer, personal communi-
cation) which is known for its broad substrate speci¢city [32].
So far nothing is known about the speci¢city of the enzyme
from low eukaryotes.
Tryparedoxin is not a substrate of E. coli thioredoxin re-
ductase (data not shown) in accordance with the high specif-
icity of the bacterial enzymes for their respective thioredoxin.
A Km value of T. brucei tryparedoxin for trypanothione was
estimated in an assay system which measures the tryparedox-
in-catalyzed reduction of GSSG by trypanothione. An appa-
rent Km value of v 150 WM was obtained which is in good
agreement with the value of 130 WM reported for C. fascicu-
lata tryparedoxin using the peroxidase/hydroperoxide system
as ¢nal electron acceptor [9].
A classical function of thioredoxins and glutaredoxins is the
delivery of reducing equivalents for ribonucleotide reductase
[2]. Preliminary studies on T. brucei ribonucleotide reductase
show that trypanothione serves as e¡ective reductant of the
enzyme and tryparedoxin strongly stimulates the overall re-
duction of GDP (M. Dormeyer and R.L. Krauth-Siegel, in
preparation).
In conclusion, T. brucei tryparedoxin containing a CPPC
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Table 1
Thiol-disul¢de reactions involving CXXC proteins
Reduction by
T(SH)2
GSH:HEDS
transhydrogenation
kapp (M31 s31)a (U/mg)
Tryparedoxin s 2.0U102 90.15
Thioredoxin 8.6 90.05
Glutaredoxin s 2.7U102 50^60
The assays were carried out as described in Section 2.
aBecause of the very high rates with tryparedoxin and glutaredoxin,
non-saturating trypanothione reductase concentrations were used; the
second order rate constants are highly underestimated values under
these conditions.
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active site motif e¡ectively catalyzes certain thiol-disul¢de ex-
changes. The nature of the two residues between the active site
cysteines strongly a¡ects the redox properties of thioredoxin-
like thiol:disul¢de oxidoreductases [1,33]. In the periplasmic
protein thiol :disul¢de oxidoreductase DsbA a mutation that
results in two central proline residues increases the redox equi-
librium constant by more than 1000-fold which results in a
more reducing protein species [33]. Recently a protein-disul-
¢de oxidoreductase has been discovered in the periplasma of
P. denitri¢cans which contains a CPPC motif and has been
proposed to reduce protein-disul¢de bonds in vivo rather than
to form them [21]. In some aspects tryparedoxin resembles a
classical thioredoxin, in others it behaves like a glutaredoxin
indicating that the parasite tryparedoxins may form a new
class of thiol-disul¢de oxidoreductases.
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